Literature DB >> 17671987

Gene transfer to the spinal cord neural scar with lentiviral vectors: predominant transgene expression in astrocytes but not in meningeal cells.

W T J Hendriks1, R Eggers, J Verhaagen, G J Boer.   

Abstract

Viral vector-mediated overexpression of neurotrophins in cells constituting the neural scar may represent a powerful approach to rendering scar tissue of a central nervous system (CNS) lesion permissive for neuronal regrowth. In this study a lentiviral vector encoding green fluorescent protein (LV-GFP) was injected in and around the neural scar 2 weeks after a dorsal column lesion in the rat spinal cord in order to analyze transduction characteristics of the neural scar after 4, 7, and 14 days. GFP expression was found at all points after injection and increased from 4 to 7 days, with no apparent difference observed between 7 and 14 days. The core of the lesion was virtually devoid of GFP signal despite direct vector injections in this area. The colocalization of GFP with specific cell markers (GFAP, vimentin, Raldh2, NeuN, OX-42, ED-1, and NG-2) indicated that the predominant cells transduced in the rim of the lesion were astrocytes, with neurons, microglia, oligodendrocyte precursors, and macrophages transduced to a lesser extent. None of the Raldh2-positive meningeal cells, present in the core of the scar, expressed GFP. In vitro meningeal cells were readily transduced, indicating that in vivo the formation of an extracellular matrix might prevent LV particles from transducing cells in the core of the scar. Because astrocytes are important cellular constituents of the glial scar after CNS injury, transduction of astrocytes with LV vectors encoding neurotrophic factors like BDNF or NT-3 may be used to enhance regeneration of severed axonal tracts through or along boundaries of a CNS lesion. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671987     DOI: 10.1002/jnr.21432

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

1.  Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries.

Authors:  Aline M Thomas; Jaime L Palma; Lonnie D Shea
Journal:  J Control Release       Date:  2015-02-24       Impact factor: 9.776

2.  Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.

Authors:  Matthew R J Mason; Erich M E Ehlert; Ruben Eggers; Chris W Pool; Stephan Hermening; Angelina Huseinovic; Eric Timmermans; Bas Blits; Joost Verhaagen
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

3.  The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5.

Authors:  M S Weinberg; B L Blake; R J Samulski; T J McCown
Journal:  Gene Ther       Date:  2011-04-14       Impact factor: 5.250

4.  Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury.

Authors:  Haruo Kanno; Yelena Pressman; Alison Moody; Randall Berg; Elizabeth M Muir; John H Rogers; Hiroshi Ozawa; Eiji Itoi; Damien D Pearse; Mary Bartlett Bunge
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

Review 5.  Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.

Authors:  Chaitanya R Joshi; Vinod Labhasetwar; Anuja Ghorpade
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-03       Impact factor: 4.147

6.  Vimentin Promotes Astrocyte Activation After Chronic Constriction Injury.

Authors:  Pengfei Xue; Liming Chen; Xiongsong Lu; Jinlong Zhang; Guofeng Bao; Guanhua Xu; Yuyu Sun; Xiaofeng Guo; Jiawei Jiang; Haiyan Gu; Zhiming Cui
Journal:  J Mol Neurosci       Date:  2017-08-08       Impact factor: 3.444

7.  Lentiviral vectors express chondroitinase ABC in cortical projections and promote sprouting of injured corticospinal axons.

Authors:  Rong-Rong Zhao; Elizabeth M Muir; João Nuno Alves; Hannah Rickman; Anna Y Allan; Jessica C Kwok; Kasper C D Roet; Joost Verhaagen; Bernard L Schneider; Jean-Charles Bensadoun; Sherif G Ahmed; Rafael J Yáñez-Muñoz; Roger J Keynes; James W Fawcett; John H Rogers
Journal:  J Neurosci Methods       Date:  2011-08-09       Impact factor: 2.390

Review 8.  Gene delivery strategies to promote spinal cord repair.

Authors:  Christopher M Walthers; Stephanie K Seidlits
Journal:  Biomark Insights       Date:  2015-04-09

9.  Intrathecal administration of IGF-I by AAVrh10 improves sensory and motor deficits in a mouse model of diabetic neuropathy.

Authors:  Judit Homs; Gemma Pagès; Lorena Ariza; Caty Casas; Miguel Chillón; Xavier Navarro; Assumpció Bosch
Journal:  Mol Ther Methods Clin Dev       Date:  2014-01-15       Impact factor: 6.698

10.  Sulfatase-mediated manipulation of the astrocyte-Schwann cell interface.

Authors:  Paul O'Neill; Susan L Lindsay; Andreea Pantiru; Scott E Guimond; Nitish Fagoe; Joost Verhaagen; Jeremy E Turnbull; John S Riddell; Susan C Barnett
Journal:  Glia       Date:  2016-08-18       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.